Carcinoid heart surgery: Review of outcomes from a single large centre

#3313

Introduction: Up to half of patients with carcinoid syndrome develop carcinoid heart disease and valve degeneration can lead to right heart failure. Surgical replacement of affected valves is an effective therapy. Peptide receptor radio-targeted therapy (PRRT) has demonstrated better progression-free survival compared to high dose sandostatin LAR.

Aim(s): To describe a cohort from a single large centre, assessing outcomes after surgery and treatment with PRRT.

Materials and methods: We reviewed the records of consecutive patients with carcinoid heart disease who underwent heart valve replacement surgery at a large single centre between 2003 - 2019. Longest follow up 9 years.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Maclean R

Authors: Maclean R, Cope J, Hota S, Mulholland N, Ramage J,

Keywords: PRRT, Lutetium, Lutathera, carcinoid syndrome, valve replacement,